Litcius/Paper detail

Engineering ROS-scavenging Prussian blue nanozymes for efficient atherosclerosis nanotherapy

Xiaoying Chen, Chen Dai, Ruizhi Hu, Luodan Yu, Yu Chen, Qi Zhang

2023Journal of Materials Chemistry B24 citationsDOI

Abstract

Prussian blue nanozymes were fabricated for atherosclerosis nanotherapy, which could reduce cellular reactive oxygen species level and exert cytoprotective effects against macrophages apoptosis, significantly boycotting atherosclerosis development.

Topics & Concepts

Prussian blueReactive oxygen speciesMaterials scienceNanotechnologyNanoparticleChemistryBiochemistryElectrodePhysical chemistryElectrochemistryAdvanced Nanomaterials in CatalysisNanoplatforms for cancer theranosticsNanocluster Synthesis and Applications
Engineering ROS-scavenging Prussian blue nanozymes for efficient atherosclerosis nanotherapy | Litcius